Concepedia

Linlin Luo

LL

23

Publications

1K

Citations

15

H-Index

2012

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Pharmerit (United States)

Pfizer (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Janssen (United States)

Linlin Luo is an author at Bristol-Myers Squibb (United States) specializing in medicine, drug analysis, and bioanalysis.

ORCID

Top concepts

Publications per year

2012–2023

23

Publications

23

MicroRNA-378a-5p promotes trophoblast cell survival, migration and invasion by targeting Nodal

Linlin Luo, Gang Ye, Lubna Nadeem et al. · Journal of Cell Science · 2012 · 156 citations · Full text

MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11

Vinayakumar Siragam, Zina Jeyapalan Rutnam, Weining Yang et al. · Oncotarget · 2012 · 133 citations · Full text

Ly6E/K Signaling to TGFβ Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance

Midrar AlHossiny, Linlin Luo, William R. Frazier et al. · Cancer Research · 2016 · 106 citations · Full text

, , +21

Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome

Linlin Luo, Peter B. McGarvey, Subha Madhavan et al. · Oncotarget · 2016 · 93 citations · Full text

Fully Validated LC-MS/MS Assay for the Simultaneous Quantitation of Coadministered Therapeutic Antibodies in Cynomolgus Monkey Serum

Hao Jiang, Jianing Zeng, Craig Titsch et al. · Analytical Chemistry · 2013 · 83 citations

, , +24

Rows per page

1–5 of 23